首页 正文

Nimotuzumab Plus Gemcitabine-based Adjuvant Chemotherapy for Resectable Pancreatic Cancer: A Retrospective Observational Study

{{output}}
Background: Adjuvant chemotherapy (AC) provides an improved long-term survival chance for those with R0/R1 resection following limited survival improvement space, as well as intolerable side effects. There is currently a gap in t... ...